Drug Pipeline

Recombinant Activated Factor VII (rFVIIa) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
2
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07157423 A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in… Severe Postpartum Haemorrhage Recruiting
Phase 3
NCT04563520 SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis Hemophilia A Recruiting
NCT03496883 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Intracerebral Hemorrhage Active, Not Recruiting
Not specified
NCT06883240 An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic… Von Willebrand Disease, Type 3 Recruiting
Sponsors Running Recombinant Activated Factor VII (rFVIIa) Trials
Joseph Broderick, MD (1) Emory University (1) Hoffmann-La Roche (1) Novo Nordisk A/S (1)
Disease Areas
Hemophilia (1)
Get alerts when Recombinant Activated Factor VII (rFVIIa) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free